Categories
Healthcare Delivery Life Sciences

Genetic profiling tests may hold the key for beating Cancer

It is vital for oncologists to get clinically actionable and timely results to decide on treatment options for patients. Keeping this in mind, StrandAdvantage, a tumor genomic profiling test by Strand Life Sciences, was launched in India about a year ago.

Strand Life Sciences is a global genomic profiling & bioinformatics company focusing on the use of precision medicine diagnostics aimed at cancer care and inherited diseases.In 2016, Strand made its new 152-gene test available to physicians across India for expanded tumor profiling, compared to the existing Tissue-Specific Tests for colon, lung, and breast cancers, and the 48-gene test for rare and aggressive cancers.